3601 - 3610 of 8571 Results
Title
Year
-
OPENTitle: Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/1694547Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/1694547.pdfCitation Count: 17
-
OPENTitle: Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.005Best OA location URL: https://doi.org/10.1016/j.parkreldis.2018.09.005Citation Count: 29
-
OPENTitle: An invisible ubiquitin conformation is required for efficient phosphorylation by PINK 1Journal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 36Issue #: 24Start Page: 3555End Page: 3572Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.15252/embj.201797876Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.201797876Citation Count: 58
-
OPENTitle: Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 18Start Page: 3487End Page: 3496Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00536Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00536Citation Count: 22
-
OPENTitle: Loss‐of‐function coding variants in the Ras of complex proteins/GTPase domain of leucine rich repeat kinase 2Journal Name: Protein SciencePublisher: WileyVol: 34Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/pro.70190Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.70190Citation Count: 1
-
OPENTitle: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease modelsJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.148649Best OA location URL: http://insight.jci.org/articles/view/148649/files/pdfCitation Count: 7
-
OPENTitle: Novel early‐onset Alzheimer‐associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathwaysJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70377Citation Count: 0
-
OPENTitle: Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 28Issue #:Start Page: 102391End Page: 102391Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2020.102391Best OA location URL: https://doi.org/10.1016/j.nicl.2020.102391Citation Count: 34
-
OPENTitle: O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effectJournal Name: Physical BiologyPublisher: IOP PublishingVol: 18Issue #: 1Start Page: 016002End Page: 016002Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1478-3975/abb6dcBest OA location URL: https://iopscience.iop.org/article/10.1088/1478-3975/abb6dc/pdfCitation Count: 18
-
RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0